Table 1. Properties of Vibrio parahaemolyticus clinical isolates from Puerto Montt, Chile, summer 2007*.
Isolate | tlh | tdh | trh | orf8 | ToxRS/new | Serotype | DGREA group | MLST ST† |
---|---|---|---|---|---|---|---|---|
PMC50.7, 51.7, 41.7, 72.7, 1.7, 15.7, 16.7 | + | + | – | + | + | O3:K6 | VpKX | 3 |
PMC55.7, 56.7, 58.7, 28.7, 44.7, 73.7, 14.7, 18.7 | + | + | – | + | + | O3:K59 | VpKX | ND |
PMC29.7, 42.7, 70.7, 11.7, 19.7 | + | + | – | + | + | O3:K6,59 | VpKX | ND |
PMC59.7, 63.7, 64.7, 65.7, 66.7, 20.7, 22.7 | + | + | – | + | + | ND | VpKX | ND |
PMC38.7, 47.7, 57.7, 68.7 | + | + | – | – | – | O10:K20 | 38.7 | 63 |
PMC60.7, 25.7, 26.7, 27.7 | + | + | + | – | – | O1:KUT | 60.7 | 64 |
PMC53.7 | + | – | – | – | – | O3:K59 | 1.5 | 28 |
PMC75.7 | + | – | – | – | – | O1:KUT | 75.7 | 65 |
*Isolates with an undetermined serotype are in boldface. orf, open reading frame; DGREA, direct genome restriction enzyme analysis; MLST, multilocus sequence typing; ST, sequence type; ND, not determined. †Sequences are available from http://pubmlst.org/vparahaemolyticus.